NCT01685151 A Safety and Efficacy Study of Ramelteon Tablets for Sublingual Administration (TAK-375SL) in the Maintenance Treatment of Bipolar 1 Disorder Status WITHDRAWN Phase PHASE3
NCT01677182 Safety and Efficacy Study of Ramelteon (TAK-375) Tablets for Sublingual Administration (SL) in Adults With Bipolar 1 Disorder Status TERMINATED Phase PHASE3
NCT01663220 Characterization of the Variability of Insulin Secretory Parameters in the Meal Tolerance and the Maximal Stimulation Tests of Subjects With Type 2 Diabetes Mellitus Status COMPLETED Phase N/A
NCT01663207 Characterization of the Variability Of Insulin Secretory Parameters in the Meal Tolerance and the Maximal Stimulation Tests of Subjects With Prediabetes Status COMPLETED Phase N/A
NCT01647542 Study to Evaluate the Efficacy and Safety of Daily Oral TAK-875 25 and 50mg in Asia Pacific Adults With Type 2 Diabetes Status TERMINATED Phase PHASE3
NCT01642615 Safety and Efficacy of Dexlansoprazole Delayed-Release Capsules for Healing of Erosive Esophagitis and Maintenance of Healed Erosive Esophagitis and Relief of Heartburn in Adolescents Status COMPLETED Phase PHASE2
NCT01642602 Safety and Efficacy of Dexlansoprazole Delayed-Release Capsules in Treating Symptomatic Non-Erosive Gastroesophageal Reflux Disease in Adolescents Status COMPLETED Phase PHASE2
NCT01639222 Human Pharmacology Trial of Calcium-vitamin D3 Tablet in Healthy Participants Status COMPLETED Phase PHASE1
NCT01637935 Cohort Study of Pioglitazone and Bladder Cancer in Patients With Type II Diabetes Status COMPLETED Phase N/A
NCT01630746 A Randomized, Double-Blind, Multicenter Study to Evaluate the Acid-inhibitory and Dose-response Efficacy of TAK-438 (20 mg, 40 mg) in Patients With Proton Pump Inhibitor (PPI) - Resistant Erosive Esophagitis Status COMPLETED Phase PHASE3
NCT01621451 Does Early Re-administration of Aspirin/Clopidogrel Increase the Risk of Bleeding From Artificial Ulcer After EMR or ESD? Status UNKNOWN Phase PHASE4
NCT01616082 Effect of Caloric Restriction on Fat Oxidation in Obese Men and Women (Magellan II) Status COMPLETED Phase NA
NCT01609582 Study of TAK-875 in Adults With Type 2 Diabetes and Cardiovascular Disease or Risk Factors for Cardiovascular Disease Status TERMINATED Phase PHASE3
NCT01582854 Efficacy and Safety of Actovegin in Post-stroke Cognitive Impairment (PSCI) Status COMPLETED Phase PHASE3
NCT01568398 A Unblinded Study of TAK-438 (20 mg) for Prevention of Recurrence of Gastric or Duodenal Ulcer During Long-Term Low-Dose Aspirin Therapy Status COMPLETED Phase PHASE3
NCT01568385 A Unblinded Study of TAK-438 (20 mg) for Prevention of Recurrence of Gastric or Duodenal Ulcer During Long-Term Non-Steroid Anti-Inflammatory Drug (NSAID) Therapy Status COMPLETED Phase PHASE3